Mozobil Coupon & Prices
Get notified when Mozobil medication is added to NiceRxGet Started Now
Secure: Your personal and medical information is safe with us
Convenient: We manage the whole process and we’re here to assist you
Ongoing refills: We request your medication refills on your behalf
NiceRx works with your healthcare provider to help you access affordable medications directly from U.S. pharmaceutical companies.
How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Mozobil cost savings if eligible
With our assistance, you could access the Mozobil patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Mozobil patient assistance?
We review each Mozobil enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Mozobil patient assistance program?
Our process makes it as easy as possible to apply for the Mozobil patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Mozobil, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Mozobil coupons provider?
NiceRx is not a Mozobil coupon, Mozobil discount card, or Mozobil copay card provider. We do not offer Mozobil manufacturer coupons, Mozobil discounts, rebates, Mozobil savings cards, trial offers, or free Mozobil samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Mozobil
- Your insurance company will not pay for your Mozobil prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Mozobil cost without insurance?
Without insurance, Mozobil’s costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Mozobil subcutaneous solution (20 mg/mL) will cost around $9,700 for 1.2 milliliters.
How much does Mozobil cost with insurance?
The copay for Mozobil will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Mozobil?
Mozobil is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Genzyme Corporation a Sanofi Company. Mozobil, a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony-stimulating factor (G-CSF) to help bone marrow release hematopoietic stem cells (HSC) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL)and multiple myeloma.
Mozobil is not intended for hematopoietic stem cell transplantation (HSCT) mobilization and collection in patients with leukemia.
What doses of Mozobil are available?
Mozobil is available in solution for subcutaneous use form, in the following doses: single-dose vials containing 1.2 mL of a 20 mg/mL solution.
Start treatment after you received G-CSF once daily for 4 days. Repeat the dose for up to 4 consecutive days. Select the dose based on 0.24 mg/kg actual body weight. Administer by subcutaneous injection approximately 11 hours before initiation of apheresis. For renal impairment, if creatinine clearance is less than 50 mLmin, decrease the dose by one-third to 0.16 mg/Kg.
Always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Mozobil active ingredients
The active ingredient of Mozobil is plerixafor which is an inhibitor of the CXCR4 chemokine receptor.
Mozobil side effects
The most common adverse reactions of Mozobil in clinical trials compared to placebo include:
- Injection site reactions
- Flatulence, abdominal pain, and vomiting
In rare instances, Mozobil can cause more serious side effects. These can include:
- Anaphylactic shock and hypersensitivity reactions
- Tumor cell mobilization in leukemia patients
- Hematologic effects – increased concentrations of leukocytes and decreased platelet counts (thrombocytopenia). Monitor blood cell counts and platelet counts
- Potential for tumor cell mobilization – tumor cells may be released from bone marrow during HSC mobilization with Mozobil and G-CSF. The effect of reinfusion of tumor cells is unknown
- Potential for splenic rupture – you will need to be evaluated if you have left upper abdominal and/or scapular or shoulder pain
- Hyperleukocytosis (increase in white blood cells)
Your doctor will assess the benefits of using Mozobil against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Mozobil to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Mozobil drug interactions
There is currently no data for Mozobil interactions with other medications. Tell your healthcare provider about all the medicines you take, including prescription drugs and over-the-counter medicines, vitamins, and herbal supplements.
You should not use Mozobil if you:
- Are allergic to the active ingredient plerixafor
- Have had an allergic reaction to any of the other ingredients in Mozobil
- Are pregnant or are planning to become pregnant – If you are a female of childbearing potential you should use an effective form of contraception during treatment and for one week after the last dose
- Are breastfeeding or are planning to breastfeed
Talk to your doctor before using Mozobil if you:
- Are taking any of the medications that could interact with Mozobil
Mozobil is the trademark brand name for plerixafor manufactured by Genzyme Corporation a Sanofi Company. A generic version of plerixafor is OR is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Mozobil savings through NiceRx.
*Qualifying persons may obtain medications directly from patient assistance programs without any out-of-pocket cost (or for less than $49 per medication). However, our monthly flat rate of just $49 per medication spares you the hassle of tracking the different programs and filling out all the required paperwork for each program. Subject to medication availability and acceptance by the pharmaceutical companies. NiceRx is not responsible for any delays or rejection by the pharmaceutical companies.
Enrollees enjoy a full-service solution, as NiceRx assists them and their physicians with the entire process. We prepare all required documents for the physician to sign, help enrollees manage all prescription refills, monitor eligibility criteria, and maintain enrollment.
**If you do not receive medications because you were determined to be ineligible for the prescription assistance by the applicable pharmaceutical companies and you have a letter of denial, we will refund any fees you paid toward medications for which you did not qualify to receive prescription assistance (“Refund”).
To receive a refund, you must send the letter of denial to us by fax to 888-517-7444, or by e-mail to [email protected] within 30 days of your receipt of such letter. The Refund is your sole and exclusive remedy for any fees you may wish to dispute.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.